Market Place
Sourcing Support
All News #Library
Others
Telomir wins FDA IND clearance for TNBC drug
30 Apr 2026 //
PHARMIWEB
Telomir Pharma Acquires TELI Pharma, Gains Global Rights
24 Apr 2026 //
FIRSTWORD PHARMA
Telomir Pharma Reveals Telomir-1 Targets New Histone Demethylase
18 Sep 2025 //
PHARMAWEB
Telomir-1 Restores Vision in AMD Model with Surrogates Endpoints
29 May 2025 //
ACCESSWIRE
Telomir-1 Reverses Decline in Autism & Spasmodic Dysphonia
07 May 2025 //
ACCESSWIRE
Telomir Pharma Reports Effects in Prostate Cancer in Animal Model
19 Mar 2025 //
ACCESSWIRE
Telomir-1 Reverses Calcium Dysregulation In Aging & Disease
26 Feb 2025 //
ACCESSWIRE
Telomir Achieves Silver Ion Stabilization Breakthrough
21 Feb 2025 //
ACCESSWIRE
Telomir Reports Reduced Oxidative Stress In Retinal Cells For AMD
18 Feb 2025 //
ACCESSWIRE
Telomir-1 Reverses Oxidative Stress, Explored for Bird Flu
28 Jan 2025 //
ACCESSWIRE
Telomir Confirms Copper Binding of Telomir-1, Wilson’s Disease
23 Dec 2024 //
ACCESSWIRE
Telomir Raises $1M In Premium No-Warrant Stock Deal At $7/Share
12 Dec 2024 //
ACCESSWIRE
Telomir Reverses Type 2 Diabetes Parameters in Preclinical Study
03 Dec 2024 //
ACCESSWIRE
Telomir Pharma Confirm Age Reversal, Longevity in Preclinical Study
21 Nov 2024 //
ACCESSWIRE
Telomir Pharmaceuticals Announces Passing Of CEO Dr. Christopher Chapman
12 Aug 2024 //
GLOBENEWSWIRE
Telomir Pharmaceuticals Added To Russell 3000 And Microcap Indexes
02 Jul 2024 //
GLOBENEWSWIRE
Telomir Pharmaceuticals Scientific Advisor To Participate In DIA 2024 Panel
17 Jun 2024 //
GLOBENEWSWIRE
Telomir Hits Milestones For Telomir-1 Candidate
30 May 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.